Hospital-acquired pneumonia

Pneumonia Main Page
Hospital-acquired pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hospital-Acquired Pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
Diagnostic Algorithm
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hospital-acquired pneumonia On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hospital-acquired pneumonia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hospital-acquired pneumonia
CDC onHospital-acquired pneumonia
Hospital-acquired pneumonia in the news
Blogs on Hospital-acquired pneumonia
Directions to Hospitals Treating Hospital-acquired pneumonia
Risk calculators and risk factors for Hospital-acquired pneumonia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Differential diagnosis

• Atelectasis
• Congestive heart failure
• Pulmonary embolism

Treatment

Usually initial therapy is empirical. If sufficient reason to suspect influenza one might consider amantadine or rimantadine. In case of legionellosis erythromicin or fluoroquinolone.

A third generation cephalosporin (ceftazidime) + carbapenems (imipenem) + beta lactam & beta lactamase inhibitors (piperacillin/tazobactum)